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Introduction
Quercetin (Q) belongs to the vast group of flavonoids
present in several edible plants, particularly in onion,
Italian cabbage, apples, and grapes. For the last
decades Q has been known as a strong antioxidant, an
anti-inflammatory agent, a vaso-dilatatory compound,
and an agent which decreases blood pressure and
inhibits aggregation of blood platelets [1-3]. Also on
multiple occasions Q was found to exert antineoplastic
effects on all stages of carcinogenesis [1,2,4,5]. How-
ever, mechanisms of Q action have not been fully
recognised and continue to provide topic for intense in
vivo and in vitro studies. Several of them showed that
Q inhibit proliferation and induce apoptosis in cells of
many tumours, including cancers of breast, lungs,
colon or gliomas [2,5-11]. In contrast, in normal cells
Q was noted to exert an anti-apoptotic effect [12,13].
Anthracyclins, including daunorubicin (DB),
belong to cytostatic antibiotics frequently applied in
chemotherapy. Cytotoxicity of DB reflects mainly its
direct effect on DNA and enzymes such as topoiso-
merase II (Topo II), generation of high amounts of free
radicals and damage to cell membrane. This results in
a disturbed replication, transcription and cellular
homeostasis, leading to apoptotic death of the cell.
Despite its high efficacy, application of DB is restrict-
ed due to the pronounced cardio-, nephro- and myelo-
toxicity. Moreover, the frequently appearing multidrug
resistance (MDR) causes that the therapy remains
without the expected result [14,15].
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The antineoplastic properties of Q are linked main-
ly with its effect on expression of some oncogens, cell
cycle-suppressory genes and their products. Q affects
directly various type kinases, e.g., protein kinase C, PI
3K, MAPK, ERK, CDK and their respective metabol-
ic pathways, which play a significant role in carcino-
genesis [16-21]. The studies on effects of carcinogens
on normal cells in presence of Q, demonstrated also its
antioxidant properties and a protective role against
mutagenesis in healthy tissues [2,22-24]. 
Q exerts influence on expression of several genes and
proteins, engaged in control of cell cycle, cell differ-
entiation, programmed cell death, processes of cells
adhesion and interactions [7,8,25]. Apart from the
direct pro-apoptotic effect on neoplastic cells, admin-
istration of some polyphenols might be useful in over-
coming MDR phenomenon acting as chemo- and pho-
tosensitizers. Results of such studies are very promis-
ing [26-29].
Considering the above data, our study aimed at
examining if Q is effective cytotoxic agent toward
selected cell lines of pancreatic carcinoma and if it
supports pro-apoptotic action of DB.
Material and methods
Cell lines and conditions of culture. The in vitro studies were
conducted on cell lines of human pancreatic carcinoma sensitive
and resistant to DB, EPP85-181P and EPP85-181RDB respective-
ly. Both cell lines were obtained from Institute of Pathology,
University Hospital Charite in Berlin where they had been estab-
lished by in vitro exposure to DB (Farmitalia Carlo Erba, Freiburg,
Germany). The cell cultures were grown in modified Leibovitz
L15 medium in a humidifed incubator at 37°C in an atmosphere of
5% CO2. The cell culture followed the description of Lage et al.
[30]. 
Proliferation tests. All proliferation tests were based on a colori-
metric technique using sulphorhodamine B (SRB) dye, as
described by Skehan et al. [31]. Substances added to the cultures, 
Q and DB, and the remaining reagents were purchased from
SIGMA (Germany). The absorbance was read at the wavelength of
564 nm using a microplate-reader (ELX-800, BIO-TEK, USA).
On the basis of preliminary tests (calibration tests for individ-
ual lines and a cytotoxic test for the two examined compounds) the
final experiment was performed, aimed to detect cytotoxic effect of
DB and Q, used separately or together in various combinations of
concentrations, on EPP85-181P and EPP85-181RDB cell lines.
The cells were transferred to 96-well plates, 800 cells per well.
Following 24 h of culture, the drugs were added in various con-
centrations and combinations (12 repetitions) as follow: 
1) Q: Q3 (3 μM), Q6 (6 μM) and Q12 (12 μM); 
2) DB: K2 (0.43 μM, the concentration corresponding to the ther-
apeutic dose of DB in patient's blood 2h after administration of the
drug, for DB it amounted to 0.25 mg/ml), K1 (0.043 μM) and K3
(4.3 μM); 
3) combinations: Q3/K1, Q3/K2, Q3/K3, Q6/K1, Q6/K2, Q6/K3,
Q12/K1, Q12/K2, Q12/K3 (the cytostatic drug was added to the
culture 2 h after addition of Q); 
4) control (with no drugs added).
Absorbance (optical density values, OD) was read after 72h
drugs exposure.
Evaluation of apoptosis. Cells of both lines were transferred to
24-well plates, at 2×104 cells/ml, the tested substances were added,
as in the case of proliferation tests, following 24 h, omitting the
combination with the K3 dose of a cytostatic drug. After 72h dam-
age to cell nuclei was detected using comet assay with neutral elec-
trophoresis, according to the procedure of Yasuhara et al. [32]. The
slides were silver-stained, as described by Cerda et al. and then
analyzed under a light microscope (Olympus BX41, Japan) [33].
The proportion of damaged cell nuclei was appraised per visual
field, taking into account a mean score following screening 5 fields
in every slide (magnification of 200×). In the neutral technique,
routinely intact cells (lack of the typical tail, normal size of the
head) were marked as 0 grade, and 4 grades of cell nucleus dam-
age are distinguished, taking into account size of the head, length
of the tail and their reciprocal ratio [32]. The obtained results were
collected and categorized to 3 ranges of cell nucleus damage: 
1) 0 – intact cell nuclei 
2) grades 1 and 2 – intermediate damage (size of the tail <50%)
3) grades 3 and 4 – apoptotic nuclei (size of the tail >50%).
In addition, the apoptotic cells were detected by the TUNEL
technique. Following 72h of incubation, cells cultured and pre-
pared as before the comet assay tests were placed on diagnostic
slides, fixed in the cold (-20°C) methanol:acetone (1:1) mixture for
15 min at the temperature of 4°C and dried with a cold air. The
apoptotic cell nuclei were detected using Apop Tag Peroxidase in
situ Apoptosis Detection kit (INTERGEN, USA), as recommend-
ed by the manufacturer. At the terminal stage of the reaction, DAB
was used as a dye and cell nuclei were counterstained with hema-
toxylin. The preparations were analyzed under a light microscope
(Olympus BX41, Japan) using a software for computer-assisted
image analysis (Analysis 3.2, Germany).
Percentage of apoptotic cell nuclei was appraised per visual
field, taking into account a mean score from 3 fields for every well
(magnification ×200) in every slide for 3 wells/repetitions. 
Statististical analysis. The obtained results were subjected to sta-
tistical analysis using Student's t-test and taking adventage of SPSS
14 software (USA). The results were regarded statistically signifi-
cant at p<0.05.
Results
Effect of DB and Q on cells proliferation
EPP85-181P line
Effect of DB and Q applied separately, as compared
to the control. The line of EPP85-181P was found to
be sensitive to action of DB in cases of all tested doses.
K1 reduced cell number by 32%, K2 by 89%, while
K3 by 94%, as compared to the control. Sensitivity of
cells to Q was also evident in every applied concentra-
tion of the polyphenol. In comparison with the control,
Q3 concentration decreased OD by 22%, Q6 by 36%,
while Q12 by as much as 74%. All differences proved
to be statistically significant (p<0.001). 
Effect of DB/Q combinations in comparison
with the action of Q alone (Fig. 1). Administration of
Q in parallel to DB, as compared to application of the
same concentration of Q alone, decreased OD in all
tested cases. The combinations with DB demonstrated
inhibition of proliferation dependent on the dose of the
cytostatic drug and the differences were statistically
significant (p<0.001).
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Effect of DB/Q combinations in comparison with
the action of DB alone (Fig. 2). Only the combina-
tions of Q6/K1 and Q12/K1 induced a statistically sig-
nificant decrease in the cell number (p<0.001) as com-
pared to the effect of the cytostatic drug alone (K1).
EPP85-181RDB line
Effect of tested substances, as compared to the con-
trol. No effect of DB on cells of the resistant line was
detected, the differences in absorbance were insignifi-
cant (p>0,05). On the other hand, Q exerted effect on
the studied cells in concentrations of Q6 and Q12. Fol-
lowing administration of Q6 OD decreased by 24%,
and following Q12 by 50%. The differences between
effects of individual doses and also between Q6 or
Q12 and the control were statistically significant
(p<0,001). The concentration of Q3 exerted no signif-
icant effect on the proliferation (p>0.05).
Effect of DB/Q combinations in comparison with
the action of Q alone (Fig. 3). Combinations of DB
and Q in comparison with the influence of Q alone
decreased OD in a statistically significant manner
(p<0.001). Only in the case of Q12/K1 the difference
was insignificant (p>0.05). 
Effect of DB/Q combinations in comparison
with the action of DB alone (Fig. 4). As compared to
the effect of DB, supplementation with Q resulted in
an additional inhibition of proliferation in cases of any
applied concentration of Q. The differences between
individual drug combinations were also statically sig-
nificant (p<0.001).
Apoptotic damage under effect of quercetin 
and daunorubicin
EPP85-181P line. As demonstrated by results of the
comet technique, pro-apoptotic action of DB, as
Fig. 4. Effect of administering various concentrations of Q and DB
on optical density (OD) for cells of EPP85-181P line, p<0.001 for
all drug combinations as compared to effect of Q alone.
Fig. 1. Effect of administering various concentrations of Q and DB
on optical density (OD) for cells of EPP85-181P line, p<0.001 for
all drug combinations as compared to effect of Q alone.
Fig. 2. Effect of administering various concentrations of Q and DB
on optical density (OD) for cells of EPP85-181P line, *p<0.001 for
combinations K1/Q vs K1, **p<0.05 for combinations K2/Q vs K2,
***p>0.05 for combinations K3/Q vs K3.
Fig. 3. Effect of administering various concentrations of Q and DB
on optical density (OD) for cells of EPP85-181RDB line, p<0.001
for all drug combinations as compared to effect of Q alone.
225Cytotoxic effect of quercetin
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(2): 225 (222-229) 
10.2478/v10042-08-0109-1
compared to the control, was noted in K2 and K3
concentrations of the cytostatic drug: in both cases
the apoptotic cell nuclei comprised around 80%. The
remaining cell nuclei (15-18%) also demonstrated
injuries, which were classified as intermediate ones.
Cell cultures supplemented with Q alone contained
around 20% of typical apoptotic cell nuclei for Q3 and
Q6, while for Q12 their number increased to 30%, as
compared to the control. In case of intermediate damage
of cell nuclei for Q3 comprised the same fraction of
apoptotic nuclei (20% each, summing up to 40% of
affected cell nuclei). For Q6 the intermediate damage
was slightly more frequent, accounting for the total frac-
tion of 50% affected nuclei. In case of Q12 only 40%
cell nuclei remained without injury, with the intermedi-
ate damage comprising 30%.
In comparison with action of DB alone, supple-
mentation with Q increased the fraction of damaged
cell nuclei. In combinations Q with K1 high levels of
intermediate damage could be noted (80%). In combi-
nations of Q3/K2, Q6/K2 the fraction of typical apop-
totic cells increased (up to 80%) as compared to K2.
Frequency of intermediate damage was lower than in
combinations with K1.
The combinations DB/Q were more effective than
action of Q alone, particularly a marked increase was
noted in the number of apoptotic cell nuclei (Fig. 5).
On the other hand, the TUNEL technique (Table 1)
demonstrated that both DB and Q exerted pro-apoptot-
ic effect on cells of the EPP85-181P line. Following
administration of Q/DB combinations the action was
synergistic. Q intensified effects of DB, particularly in
presence of the lowest DB concentration of K1.
Administration of Q12/K1 yielded the same effect as
the tenfold higher, therapeutic dose of DB (K2) did.
K2 exerted such a high effect alone that supplementa-
tion with the polyphenol yielded not so pronounced
changes.
EPP85-181RDB line. In the case of resistant cell
line of pancreatic carcinoma DB induced apoptotic
injury only in a low percentage of cell nuclei, exam-
ined using the comet technique.
Q induced damage in cell nuclei in all applied con-
centrations. In cases of Q3 and Q6 the fraction of dam-
aged cell nuclei was low (around 6 – 6.5%), but for
Q12 it increased to 17%. In every case the intermedi-
ate damage was rare. The highest percentage of all
damaged cell nuclei, 20%, was observed for Q12.
Administration of Q/DB combination increased fre-
quency of damaged cell nuclei as compared to action of
DB alone. In the cases of combinations with K1 signif-
icant alterations and increased number of cell nuclei
with intermediate damage in particular could be noted
only for Q12/K1. More pronounced differences could
be observed in all K2 combinations with Q (Fig. 5). 
On the other hand, comparison between influence
of Q concentration alone and combinations DB/Q has
shown rising fraction of apoptotic cells in the case of
suplementation with Q12. The combinations with
cytostatic drug significantly augmented frequency of
apoptotic changes, particularly of intermediate damage
(Table 2).
TUNEL technique (Table 1) demonstrated no signif-
icant apoptotic alterations in the resistant cells following
administration of DB alone, Q3 or Q6 concentrations or
combinations of these polyphenol concentrations with
the cytostatic drug. Only in the case of Q12 concentra-
Table 1. Effect [%] of Q and DB on cells of EPP85-181P (P) and
EPP85-181RDB (RDB) lines, examined by the TUNEL technique.
Fig. 5. Effect of Q12 administration and its supplementation with
DB on proportion of damaged cell nuclei [%] in EPP85-181P cell
line.
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tion (Fig. 6A), in combinations of Q12/K1 (Fig. 6B) and
Q12/K2 an evident pro-apoptotic effect could be noted. 
Discussion
A flavonol quercetin (Q), the in vitro activity of
which on selected neoplastic cell lines provided topic
for this study, is commonly present in vegetables and
fruits [2]. Two cell lines of human pancreatic cancer,
a sensitive and a resistant to DB, provided the cell
models.
Tests of cytotoxicity showed that Q inhibits cell
divisions in the both studied neoplastic cell lines in a
time- and concentration-dependent manner. The subse-
quent step involved testing if Q accentuates anti-pro-
liferative effect in the sensitive cell line of human pan-
creatic carcinoma and if it sensitizes cells to action of
a cytostatic drug in the case of the resistant cell line.
The experiment was conducted using standard doses
of DB, the therapeutic one, the tenfold lower and 
the tenfold higher one. In the case of Q the priority was
to select as low as possible doses, as compared to the
commonly used ones, to exclude their possible toxic
effect on normal cells. Anti-proliferative action on
neoplastic cells of various plant polyphenols including
Q is commonly known and proven [34,35]. In parallel,
its protective role is stressed in respect to normal cells,
related to its antioxidative, anti-inflammatory, cardio-
protective, neuroprotective and anti-carcinogenic
effects [10,36-39]. It has also been suggested that
exists possibility of some toxic effect of Q, even in
normal cells, particularly following supplementation
of high doses of the flavonol. Therefore, results of
studies on its interactions with various drugs seems
relatively controversial [7,13,40,41].
Our studies showed that both studied compounds
exert effect on the sensitive cell line. Administration of
the cytostatic drug alone in its therapeutic dose abol-
ished cell proliferation almost completely. A strong
anti-proliferative effect was manifested also by 
Q alone, particularly its Q6 and Q12 concentrations.
Applied together, Q and DB acted synergistically on 
P cells, which could have been observed on the exam-
ple of the lowest concentration of K1. The result sug-
gests that in cases of cells sensitive to cytostatics
administration of Q might allow to significantly
decrease doses of the drug. This effect might be linked
to strong inhibition of topo II by both compounds
[18,42]. The decrease in therapeutic dose of DB may
prove important due to the chance for prevention of
negative side effects induced by the drug, assuming
that Q acts selectively: it inhibits proliferation only in
neoplastic cells in parallel protecting normal tissues
[13,21,36]. 
In the case of the studied resistant cell line, admin-
istration of polyphenol alone significantly inhibited
proliferation, particularly in its Q12 concentration.
Application of Q in combination with DB evidently
intensified the effect. Most probably, Q sensitizes neo-
plastic cells resistant to anti-proliferative action of DB
in the manner dependent on Q concentration and, to a
slightly lower extent, on dose of the cytostatic drug.
The results corroborate data obtained by other investi-
gation centres [9,43,44].
The subsequent step involved examination if the
reduced number of cells reflects only more pro-
Table 2. Effect [%] of various Q and DB combinations on nuclear damage in cells of 85-181RDB cell line, as compared to effect of 
Q alone, examined by the comet technique, C – control.
Fig. 6. DNA damage, apoptotic
nuclei stained brown. TUNEL tech-
nique, original magnification ×400.
(A) Cells of EPP85-181RDB line
subjected to action of Q12. (B)
Cells of EPP85-181RDB line sub-
jected to action of Q12/K1.
nounced inhibition of cell divisions or Q sensitizes the
resistant cells to action of DB, inducing their death by
apoptosis and, also, if Q may amplify the effect in cells
of pancreatic carcinoma cells line sensitive to DB.
The vast literature devoted to Q shows that it man-
ifests pro-apoptotic properties, as documented in cases
of multiple types of tumours [45-47]. Most probably,
this involves the late type apoptosis, developing along
the mitochondrial pathway, sometimes independent of
death receptors (through effects on MAPK, ERK
kinases, protein kinase C, proteins of Bcl family or
caspases), which was proven on the example of
melanoma cells [48]. Additionally, quercetin augments
TRAIL-induced apoptosis by affecting the ERK signal
transduction pathway [20]. Q may affect also tran-
scription factors, products of suppressor genes in the
cell cycle, e.g. p-53. In cases of mutations in this type
regulatory proteins, Q mobilizes apoptosis along other
pathways, independent of p-53 protein, which was
documented i.e. for cells of prostate cancer [9,17,49].
It is also known that Q may trigger apoptosis in cells
of several types of tumours, including pancreatic car-
cinoma. Additional analysis of apoptosis-linked genes
in several of them demonstrated increased expression
in presence of as low as 5 μM concentration of Q
[7,48-50]. Moreover, Q does not induce apoptosis in
normal cells in concentrations around 10 µM and,
reciprocally, in such a situation it may protect cells
from oxidative stress, inhibit apoptosis and supress
neoplastic transformation [13,37,40,51,52].
In case of the sensitive cells, the comet technique
proved pro-apoptotic effects of Q and DB, when
applied separately. The tendency persisted in the case
of Q/DB combination, in which both Q and DB con-
centrations were important. This points to a synergistic
effect of the two substances. It should be accentuated
that apoptosis was strongly intensified after treatment
with Q12 and its combinations with DB (3 and 4 grade
according to Yashuara et al.), while the remaining
combinations have contained high fraction of interme-
diate damage (grades 1 and 2 according to Yashuara et
al.) [32]. Intensity of apoptosis examined using the
TUNEL technique proved slightly lower than that doc-
umented by the comet technique but the general ten-
dencies were confirmed. 
In the resistant cell line pro-apoptotic effects could
have been demonstrated by the comet assay only for
Q12 concentration and its combinations with individ-
ual doses of DB. On this basis it might be assumed that
Q concentrations lower than 12 μM inhibit cell divi-
sions (cell number lower than in the control) but they
do not mobilize the apoptotic process. This was also
evident that the action of Q12 with combination with
DB is augmented in comparison with the effects of the
Q and DB given separately. These tendencies were
confirmed using TUNEL technique.
The above data are consistent with results which
suggested that Q it is able to act synergistically with
other pro-apoptotic drugs and, in the cases of cells
resistant to cytostatic drugs, it may sensitize such cells
to action of the cytostatics [25,50]. 
On the basis of multi-annual studies Q, even in its
high concentrations, is known to protect normal cells
from toxins and oxidative stress, rather than exert neg-
ative side effects [2,53]. Q acts as a strong anti-oxidant
in cases of cells such as epithelium of renal tubuli, car-
diomyocytes or bone marrow cells and, therefore, it
may protect against cardio-, myelo- or nephrotoxicity
of the cytostatic drugs, including DB [13,44,53-55].
The described by some research teams mutagenic
action of Q on normal cells was probably linked to
administration of very high doses, most frequently
exceeding 50 μM. In cases of low concentrations 
(<20 μM) Q also affects genes but it is not a genotox-
ic or carcinogenic effect. Analysis of various investi-
gations performed during several years, including 
in vivo, in vitro and clinical studies, confirmed by
detailed analysis of several genes expression, corrobo-
rate the thesis [56-58]. 
Results of our studies confirmed that Q sensitizes
cells of human pancreatic carcinoma line resistant to
DB. It seems promising for the therapy of tumours
manifesting drug resistance. Moreover, Q amplifies
action of the cytostatic drug on cells of the sensitive
line, which provides perspective for decreasing dosage
of the drug. This might be particularly valuable that the
synergistic effects of Q and DB in their antiprolifera-
tive and pro-apoptotic actions take place only in cases
of neoplastic cells, while normal cells in parallel are
protected, also against toxic action of cytostatic drugs
[3,16,51].
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